# Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics

> **NCT04465175** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Oman Medical Speciality Board** · enrollment: 90 (estimated)

## Conditions studied

- Asthma in Children

## Interventions

- **DRUG:** Magnesium Sulfate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04465175
- **Lead sponsor:** Oman Medical Speciality Board
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2020-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04465175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04465175, "Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04465175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*